Proteasomal inhibition alters the trafficking of the neurotrophin receptor TrkA

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 360-364

  Moises, T ^a   Wuller S ^a   Saxena, S ^b   Senderek, J ^a   Weis, J ^a   Kruttgen A ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

BDNF; Neurodegeneration; Neurotrophin; Proteasome; Rab11; Rab7; Traffic; TrkA; TrkB; Ubiquitin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LACTACYSTIN; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN TYROSINE KINASE A; RAB11 PROTEIN; RAB7 PROTEIN; RECOMBINANT NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENDOSOME; ENZYME ACTIVITY; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; APOPTOSIS; ENDOSOMES; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; NEURONS; PC12 CELLS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; RATS; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 67949103431     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.032     Document Type: Article

References (29)

1. Bibel M., Hoppe E., and Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors Trk and p75NTR. EMBO J. 18 (1999) 616-622
2. Ginty D.D., and Segal R.A. Retrograde neurotrophin signaling: Trk-ing along the axon. Curr. Opin. Neurobiol. 12 (2002) 268-274
3. MacInnis B.L., and Campenot R.B. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 295 (2002) 1536-1539
4. Bronfman F.C., Escudero C.A., Weis J., and Kruttgen A. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 67 (2007) 1183-1203
5. Hammond D.E., Carter S., McCullough J., Urbe S., Vande Woude G., and Clague M.J. Endosomal dynamics of Met determine signaling output. Mol. Biol. Cell 14 (2003) 1346-1354
6. Arevalo J.C., Waite J., Rajagopal R., Beyna M., Chen Z.Y., Lee F.S., and Chao M.V. Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination. Neuron 50 (2006) 549-559
7. Sommerfeld M.T., Schweigreiter R., Barde Y.A., and Hoppe E. Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J. Biol. Chem. 275 (2000) 8982-8990
8. Geetha T., and Wooten M.W. TrkA receptor endolysosomal degradation is both ubiquitin and proteasome dependent. Traffic 9 (2008) 1146-1156
9. Paul S. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 30 (2008) 1172-1184
10. Saxena S., Howe C.L., Cosgaya J.M., Steiner P., Hirling H., Chan J.R., Weis J., and Kruttgen A. Differential endocytic sorting of p75NTR and TrkA in response to NGF: a role for late endosomes in TrkA trafficking. Mol. Cell Neurosci. 28 (2005) 571-587
11. Rideout H.J., Larsen K.E., Sulzer D., and Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78 (2001) 899-908
12. Longva K.E., Blystad F.D., Stang E., Larsen A.M., Johannessen L.E., and Madshus I.H. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156 (2002) 843-854
13. Gentzsch M., Chang X.B., Cui L., Wu Y., Ozols V.V., Choudhury A., Pagano R.E., and Riordan J.R. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15 (2004) 2684-2696
14. Sadoul R., Fernandez P.A., Quiquerez A.L., Martinou I., Maki M., Schroter M., Becherer J.D., Irmler M., Tschopp J., and Martinou J.C. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15 (1996) 3845-3852
15. MacInnis B.L., and Campenot R.B. Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway. Mol. Cell Neurosci. 28 (2005) 430-439
16. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6 (2003) 231-242
17. Song E.J., Hong H.M., and Yoo Y.S. Proteasome inhibition induces neurite outgrowth through posttranslational modification of TrkA receptor. Int. J. Biochem. Cell Biol. (2008)
18. Howe C.L., Valletta J.S., Rusnak A.S., and Mobley W.C. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 32 (2001) 801-814
19. Delcroix J.D., Valletta J.S., Wu C., Hunt S.J., Kowal A.S., and Mobley W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39 (2003) 69-84
20. MacDonald J.I., Verdi J.M., and Meakin S.O. Activity-dependent interaction of the intracellular domain of rat TrkA with intermediate filament proteins, the beta-6 proteasomal subunit, Ras-GRF1, and the p162 subunit of eIF3. J. Mol. Neurosci. 13 (1999) 141-158
21. Laser H., Mack T.G., Wagner D., and Coleman M.P. Proteasome inhibition arrests neurite outgrowth, causes "dying-back" degeneration in primary culture. J. Neurosci. Res. 74 (2003) 906-916
22. MacInnes N., Iravani M.M., Perry E., Piggott M., Perry R., Jenner P., and Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. J. Neural. Transm. 115 (2008) 869-878
23. Rideout H.J., Dietrich P., Wang Q., Dauer W.T., and Stefanis L. Alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons. J. Biol. Chem. 279 (2004) 46915-46920
24. Keck S., Nitsch R., Grune T., and Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85 (2003) 115-122
25. Mishra R.S., Bose S., Gu Y., Li R., and Singh N. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. J. Alzheimer's Dis. 5 (2003) 15-23
26. Urushitani M., Kurisu J., Tsukita K., and Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 83 (2002) 1030-1042
27. Saxena S., Cabuy E., and Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12 (2009) 627-636
28. Wang C.E., Tydlacka S., Orr A.L., Yang S.H., Graham R.K., Hayden M.R., Li S., Chan A.W., and Li X.J. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum. Mol. Genet. 17 (2008) 2738-2751
29. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555